Darryl P Leong
Overview
Explore the profile of Darryl P Leong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
158
Citations
4051
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Leong D, Bosch J, Eikelboom J
Can J Cardiol
. 2024 Aug;
41(1):113.
PMID: 39173713
No abstract available.
12.
Khetan A, Palileo-Villanueva L, Mat-Nasir N, Ismail R, Dans A, Abat M, et al.
JACC Asia
. 2024 Aug;
4(8):624-633.
PMID: 39156511
Background: The drivers of cardiovascular disease (CVD) and all-cause mortality may differ around the world. Regional-level prospective data can help guide policies to reduce CVD and all-cause mortality. Objectives: This...
13.
Joundi R, Hu B, Rangarajan S, Leong D, Islam S, Smith E, et al.
Lancet
. 2024 Jul;
404(10452):554-569.
PMID: 39068950
Background: The focus of most epidemiological studies has been mortality or clinical events, with less information on activity limitations related to basic daily functions and their consequences. Standardised data from...
14.
Leong D, Dokainish H, Mondesert B, Cavalli G, Khetan A, Cirne F, et al.
JACC Clin Electrophysiol
. 2024 Jul;
10(9):2088-2096.
PMID: 39001765
Background: There are no randomized data to inform the extent to which transvenous cardiac leads cause tricuspid regurgitation (TR). Objectives: This study sought to determine the effect of a transvenous...
15.
Leong D, Bosch J, Bhatt D, Avezum A, Yuan F, Yusuf S, et al.
Can J Cardiol
. 2024 Jun;
41(1):102-111.
PMID: 38914270
Background: Individuals with frailty are at higher risk of adverse cardiovascular outcomes and bleeding. The objective of this study was to determine whether the effects of 2.5 mg rivaroxaban twice...
16.
Upshaw J, Parson S, Buchsbaum R, Schlam I, Ruddy K, Durani U, et al.
JACC CardioOncol
. 2024 May;
6(2):322-324.
PMID: 38773999
No abstract available.
17.
Haider I, Leong D, Louzada M, McCurdy A, Pond G, Cameron R, et al.
Leuk Lymphoma
. 2024 Apr;
65(8):1167-1174.
PMID: 38625039
There is limited knowledge regarding the prevalence of geriatric impairments and frailty among patients with multiple myeloma (MM) in a real-world setting. This study evaluated the distribution of frailty profiles...
18.
Leong D, Loeb M, Mony P, Rangarajan S, Mushtaha M, Miller M, et al.
Microbiol Spectr
. 2024 Jan;
12(2):e0149223.
PMID: 38214526
There are limited data on individual risk factors for SARS-CoV-2 infection (including unrecognized infection). In this seroepidemiologic substudy of an ongoing prospective cohort study of community-dwelling adults, participants were thoroughly...
19.
Magnussen C, Leong D, Blankenberg S
N Engl J Med
. 2023 Dec;
389(25):2401-2402.
PMID: 38118041
No abstract available.
20.
Nelson A, Lopes R, Hong H, Hua K, Slovin S, Tan S, et al.
JACC CardioOncol
. 2023 Nov;
5(5):613-624.
PMID: 37969642
Background: Androgen deprivation therapy is the cornerstone of treatment for patients with advanced prostate cancer. Meta-analysis of small, oncology-focused trials suggest gonadotropin-releasing hormone (GnRH) antagonists may be associated with fewer...